CVS Health Cuts 2024 Guidance, Citing ‘Potential Implications’ of Higher Medical Costs
Wall Street Journal
The healthcare company’s revised earnings projections are likely to add to investor uncertainty about the Medicare Advantage business.
https://www.wsj.com/articles/cvs-q4-earnings-report-2023-03af95d3